Old Web
English
Sign In
Acemap
>
authorDetail
>
Alan M. Christenfeld
Alan M. Christenfeld
Tremelimumab
Biomarker (medicine)
Medicine
CTLA-4
Oncology
2
Papers
33
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab
2018
Journal for ImmunoTherapy of Cancer
Philip Friedlander
Kevin Wood
Karl Wassmann
Alan M. Christenfeld
Nina Bhardwaj
William Oh
Show All
Source
Cite
Save
Citations (16)
Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab
2017
Journal for ImmunoTherapy of Cancer
Philip Friedlander
Karl Wassmann
Alan M. Christenfeld
David E. Fisher
Chrisann Kyi
John M. Kirkwood
Nina Bhardwaj
William K. Oh
Show All
Source
Cite
Save
Citations (17)
1